Scary science: Ondansetron safety in pregnancy-two opposing results from the same danish registry

Gideon Koren

doi:10.1097/FTD.0000000000000020

Scary science: Ondansetron safety in pregnancy-two opposing results from the same danish registry

Gideon Koren

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Abstract

While perceived safe in pregnancy, several recent studies raise concerns about both fetal and maternal safety of ondansetron. Until more data are available, it should not be a first-line medication for morning sickness.

Original language	English
Pages (from-to)	1-2
Number of pages	2
Journal	Therapeutic Drug Monitoring
Volume	36
Issue number	1
DOIs	https://doi.org/10.1097/FTD.0000000000000020
State	Published - Feb 2014
Externally published	Yes

Access to Document

10.1097/FTD.0000000000000020

Cite this

@article{1da079e67d2e4a69a5f5a2c016eb1b48,

title = "Scary science: Ondansetron safety in pregnancy-two opposing results from the same danish registry",

abstract = "While perceived safe in pregnancy, several recent studies raise concerns about both fetal and maternal safety of ondansetron. Until more data are available, it should not be a first-line medication for morning sickness.",

author = "Gideon Koren",

year = "2014",

month = feb,

doi = "10.1097/FTD.0000000000000020",

language = "אנגלית",

volume = "36",

pages = "1--2",

journal = "Therapeutic Drug Monitoring",

issn = "0163-4356",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Scary science

T2 - Ondansetron safety in pregnancy-two opposing results from the same danish registry

AU - Koren, Gideon

PY - 2014/2

Y1 - 2014/2

N2 - While perceived safe in pregnancy, several recent studies raise concerns about both fetal and maternal safety of ondansetron. Until more data are available, it should not be a first-line medication for morning sickness.

AB - While perceived safe in pregnancy, several recent studies raise concerns about both fetal and maternal safety of ondansetron. Until more data are available, it should not be a first-line medication for morning sickness.

UR - https://www.scopus.com/pages/publications/84892913741

U2 - 10.1097/FTD.0000000000000020

DO - 10.1097/FTD.0000000000000020

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???

AN - SCOPUS:84892913741

SN - 0163-4356

VL - 36

SP - 1

EP - 2

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

IS - 1

ER -

Scary science: Ondansetron safety in pregnancy-two opposing results from the same danish registry

Abstract

Access to Document

Other files and links

Fingerprint

Cite this